<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nefr</journal-id><journal-title-group><journal-title xml:lang="ru">Нефрология</journal-title><trans-title-group xml:lang="en"><trans-title>Nephrology (Saint-Petersburg)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1561-6274</issn><issn pub-type="epub">2541-9439</issn><publisher><publisher-name>Pavlov First Saint-Petersburg State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.36485/1561-6274-2021-25-4-82-89</article-id><article-id custom-type="elpub" pub-id-type="custom">nefr-2013</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ. ЭКСПЕРИМЕНТАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES. EXPERIMENTAL INVESTIGATION</subject></subj-group></article-categories><title-group><article-title>Влияние длительного потребления рациона с высоким содержанием хлорида натрия на экспрессию микроРНК в сыворотке крови и моче яванских макак</article-title><trans-title-group xml:lang="en"><trans-title>Effect of long-term consumption of a diet with a high  sodium chloride content on microRNA expression in blood serum and urine of Cynomolgus Macaques</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7532-2405</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Береснева</surname><given-names>О. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Beresneva</surname><given-names>O. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Береснева Ольга Николаевна, канд. биол. наук, научно-исследовательский институт нефрологии, лаборатория клинической физиологии почек, старший научный сотрудник</p><p>197022, Россия, Санкт-Петербург, ул. Л. Толстого, д. 17, корп. 54</p><p>Тел.: (812) 346-39-26</p></bio><bio xml:lang="en"><p>Olga N. Beresneva, PhD, Research Institute of Nephrology Laboratory of Clinical Physiology of the Kidney, Senior researcher</p><p>197022, Russia, St-Petersburg, L.Tolstoy st., 17, build. 54. </p><p>Phone (812)346-39-26</p></bio><email xlink:type="simple">beresnevaolga@list.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4526-8671</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Парастаева</surname><given-names>М. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Parastaeva</surname><given-names>M. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Парастаева Марина Магрезовна, канд. биол. наук, научно-исследовательский институт нефрологии, лаборатория клинической физиологии почек, старший научный сотрудник</p><p>197022, Россия, Санкт-Петербург, ул. Л. Толстого, д. 17, корп. 54</p><p>Тел.: (812) 346-39-26</p></bio><bio xml:lang="en"><p>Marina M. Parastaeva, PhD, Research Institute of Nephrology Laboratory of Clinical Physiology of the Kidney, Senior researcher</p><p>197022, Russia, St-Petersburg, L.Tolstoy st., 17, build. 54</p><p>Phone (812)346-39-26</p></bio><email xlink:type="simple">marina_parastaeva@list.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7605-4369</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зарайский</surname><given-names>М. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Zaraiski</surname><given-names>M. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Проф. Зарайский Михаил Игоревич, д-р мед. наук, кафедра клинической лабораторной диагностики с курсом молекулярной медицины</p><p>197022, Россия, Санкт-Петербург, ул. Л. Толстого, д. 17, корп. 54. </p></bio><bio xml:lang="en"><p>Prof. Mikhail I. Zaraiski, MD, PhD, DMedSci, Department of Clinical Laboratory Diagnostics with a Course of Molecular Medicine</p><p>197022, Russian Federation, Saint Petersburg, L. Tolstoy st., 17, build 54. </p></bio><email xlink:type="simple">mzaraiski@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5722-8693</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хасун</surname><given-names>М.</given-names></name><name name-style="western" xml:lang="en"><surname>Khasun</surname><given-names>Mohamad</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мохамад Хасун, канд. мед. наук, кафедра пропедевтики внутренних болезней, ассистент кафедры</p><p>197022, Россия, Санкт-Петербург, ул. Л. Толстого, д. 17, корп. 54</p><p>Тел.: +7(812)346-39-26</p></bio><bio xml:lang="en"><p>Mohamad Khasun, MD, PhD, Department of Propedeutics of Internal Diseases, Assistant</p><p>197022, Russian Federation, Saint Petersburg, L.Tolstoy st., 17, build 54</p><p>Phone: +7(812)346-39-26</p></bio><email xlink:type="simple">nefrolog2013@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5616-3488</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кучер</surname><given-names>А. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Kucher</surname><given-names>A. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Проф. Кучер Анатолий Григорьевич, д-р мед. наук, кафедра пропедевтики внутренних болезней</p><p>197022, Россия, Санкт-Петербург, ул. Л. Толстого, д. 17, корп. 54 </p><p>Тел.: +7(921)421-18-17</p></bio><bio xml:lang="en"><p>Prof. Anatoly G. Kucher, MD, PhD, DMedSci, Department of Propedeutics of Internal Diseases</p><p>197022, Russian Federation, Saint Petersburg, L. Tolstoy st., 17, build 54</p><p>Phone: +7(921)421-18-17</p></bio><email xlink:type="simple">prof.kucher@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Первый Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Pavlov University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Первый Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова; Северо-Западный государственный медицинский университет им. И.И.Мечникова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Pavlov University; North-Western State Medical University named after I.I. Mechnikov</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>16</day><month>07</month><year>2021</year></pub-date><volume>25</volume><issue>4</issue><fpage>82</fpage><lpage>89</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Береснева О.Н., Парастаева М.М., Зарайский М.И., Хасун М., Кучер А.Г., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Береснева О.Н., Парастаева М.М., Зарайский М.И., Хасун М., Кучер А.Г.</copyright-holder><copyright-holder xml:lang="en">Beresneva O.N., Parastaeva M.M., Zaraiski M.I., Khasun M., Kucher A.G.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.nephrolog.ru/jour/article/view/2013">https://journal.nephrolog.ru/jour/article/view/2013</self-uri><abstract><sec><title>ВВЕДЕНИЕ</title><p>ВВЕДЕНИЕ. Высокое поступление хлорида натрия с пищей ассоциируется с повреждением не только сердечно-сосудистой системы, но и почек. Механизмы негативного воздействия высокосолевых рационов на почки не установлены. Одним из важных звеньев в данном процессе могут служить микроРНК, обладающие способностью модулировать экспрессию генов на посттранскрипционном уровне. Неизвестно также, могут ли протеины сои противостоять ремоделированию почек, ассоциированному с повышенным потреблением поваренной соли.</p></sec><sec><title>ЦЕЛЬ ИССЛЕДОВАНИЯ</title><p>ЦЕЛЬ ИССЛЕДОВАНИЯ: оценить уровни экспрессии миРНК-133 и 203 в сыворотке крови и моче и миРНК-21 в моче яванских макак, получавших длительное время рационы с различным содержанием поваренной соли, включающие и невключающие соевые протеины. </p></sec><sec><title>МАТЕРИАЛЫ И МЕТОДЫ</title><p>МАТЕРИАЛЫ И МЕТОДЫ. Исследованы 3 группы (по 6 особей в каждой) самцов яванских макак в возрасте 6–8 лет. Первая группа (контроль) получала стандартный рацион, вторая – рацион с высоким содержанием поваренной соли (8 г NaCl/кг корма), третья – рацион с высоким содержанием соли в сочетании с соевым протеином SUPRO 760 (200 г белка/кг корма). Через 12 мес у животных измеряли АД. В моче обезьян определяли относительные уровни экспрессии микроРНК- 21, микроРНК-133 и микроРНК-203, в сыворотке крови – уровни экспрессии микроРНК-133 и микроРНК-203.</p></sec><sec><title>РЕЗУЛЬТАТЫ</title><p>РЕЗУЛЬТАТЫ. За время наблюдения в контрольной группе не зарегистрировано существенных изменений исследованных показателей. У животных, получавших в течение года высокосолевые рационы, артериальное давление также значимо не менялось. Не выявлено изменения уровня экспрессии миРНК-133 в сыворотке крови обезьян, получавших высокосолевой рацион и стандартную белковую диету. Однако у макак, потреблявших диету с высоким содержанием соли в сочетании с соевым белком, уровень экспрессии данного миРНК в сыворотке значимо снижался. Экспрессия миРНК -203 в сыворотке крови существенно не менялась. В контрольной группе не выявлены изменения экспрессии миРНК-21 в моче. В двух других выборках имел место рост данного параметра по сравнению с начальными величинами. Оба высокосолевых рациона приводили к значимому нарастанию относительного уровня экспрессии миРНК-133 в моче по сравнению с базальными значениями. Однако рост этого показателя в группе животных, получавших высокосолевую диету в сочетании с соевым изолятом, был значимо меньше, чем у макак, находящихся только на высокосолевом рационе. Экспрессия миРНК-203 в моче достоверно повышалась только в группе с высоким содержанием поваренной соли без добавления соевого протеина.</p></sec><sec><title>ЗАКЛЮЧЕНИЕ</title><p>ЗАКЛЮЧЕНИЕ. Возможно, что воздействие высокосолевых рационов на почки может опосредоваться эпигеномными механизмами и частично модулироваться включением в диету изолированных соевых протеинов.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>INTRODUCTION</title><p>INTRODUCTION. A high intake of sodium chloride from food is associated with damage not only to the cardiovascular system but also to the kidneys. The mechanisms of the negative effects of high-salt diets on the kidneys have not been established. One of the important links in this process can be microRNAs, which can modulate gene expression at the post-transcriptional level. It is also not known whether soy proteins can counter the kidney remodeling associated with increased salt intake.</p></sec><sec><title>THE AIM</title><p>THE AIM. To estimate the expression levels of miRNA-133 and 203 in blood serum and urine and miRNA-21 in the urine of cynomolgus macaques received diets for a long time with various table salt contents, including and not including soy proteins.</p></sec><sec><title>MATERIALS AND METHODS</title><p>MATERIALS AND METHODS. Three groups (6 individuals in each) of male cynomolgus macaques at the age of 6–8 years were studied. The first group (control) received a standard diet, the second – a diet with a high content of table salt (8 g NaCl / kg feed), the third – a diet with high salt content in combination with SUPRO 760 soy protein (200 g protein/kg feed). Blood pressure was measured in animals 12 months later. In monkey urine, the relative expression levels of miRNA-21, miRNA-133, and miRNA-203 were determined, in blood serum – the expression levels of miRNA-133 and miRNA-203.</p></sec><sec><title>RESULTS</title><p>RESULTS. During the follow-up period in the control group, there were no significant changes in the studied parameters. In the groups that received high-salt diets throughout the year, blood pressure also did not change significantly. There was no change in the level of expression of miRNA-133 in the blood serum of monkeys fed a high-salt diet and a standard protein diet. However, in macaques fed a diet high in salt in combination with soy protein, the serum expression of this miRNA was significantly reduced. The expression of miRNA-203 in blood serum did not change significantly. In the control group, there were no changes in the expression of miRNA-21 in urine. In the other two samples, this parameter increased in comparison with the initial values. Both high-salt diets resulted in a significant increase in the relative level of miRNA-133 expression in urine compared to basal values. However, the increase in this indicator in the group of animals fed a high-salt diet in combination with soy isolate was significantly less than in monkeys fed only a high-salt diet. Expression of miRNA-203 in urine was significantly increased only in the group with a high content of table salt without added soy protein.</p></sec><sec><title>CONCLUSIONS</title><p>CONCLUSIONS. It is possible that the effects of high-salt diets on the kidney may be mediated by epigenomic mechanisms and partially modulated by the inclusion of isolated soy proteins in the diet.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>яванские макаки</kwd><kwd>высокосолевой рацион</kwd><kwd>соевый белок</kwd><kwd>артериальное давление</kwd><kwd>экспрессия миРНК</kwd></kwd-group><kwd-group xml:lang="en"><kwd>cynomolgus macaques</kwd><kwd>high-salt diet</kwd><kwd>soy protein</kwd><kwd>blood pressure</kwd><kwd>miRNA expression</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Работа выполнена при поддержки Российского  фонда фундаментальных исследований (грант 19- 015-00221 «Физиологические механизмы адаптации  сердечно-сосудистой системы и почек к высокому поступлению хлорида натрия с пищей у млекопитающих  разных видов»)</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Felder RA, White MJ, Williams SM, Jose PA. Diagnostic tools for hypertension and salt sensitivity testing. Curr Opin Nephrol Hypertens 2013; 22(1):65–76. doi: 10.1097/MNH.0b013e32835b36934-8b013e32835b3693</mixed-citation><mixed-citation xml:lang="en">Felder RA, White MJ, Williams SM, Jose PA. Diagnostic tools for hypertension and salt sensitivity testing. Curr Opin Nephrol Hypertens 2013; 22(1):65–76. doi: 10.1097/MNH.0b013e32835b36934-8b013e32835b3693</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Парастаева ММ, Береснева ОН, Иванова ГТ и др. Артериальная гипертензия и потребление соли: вклад в ремоде- лирование сердца. Нефрология 2016; 20(5):97–105</mixed-citation><mixed-citation xml:lang="en">Parastaeva MM, Beresneva ON, Ivanova GT et al. Hypertension and salt intake: contribution to cardiac remodeling. Nephrology(Saint-Petersburg) 2016;20(5):97–105. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Береснева ОН, Парастаева ММ, Иванова ГТ и др. Изменения сердечно-сосудистой системы у крыс, сопряженные с высоким потреблением хлорида натрия. Артериальная гипертензия 2014;20(5):384–390</mixed-citation><mixed-citation xml:lang="en">Beresneva ON, Parastaeva MM, Ivanova GT at al. Changes in the cardiovascular system in rats associated with high consumption of sodium chloride. Arterial hypertension 2014; 20(5):384–390. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Grigorova YN, Wei W, Petrashevskaya N et al. Dietary sodium restriction reduces arterial stiffness, vascular TGF-β-dependent fibrosis and marinobufagenin in young normotensive rats. Int J MolSci 2018;19(10): pii:E3168. doi: 10.3390/ijms19103168</mixed-citation><mixed-citation xml:lang="en">Grigorova YN, Wei W, Petrashevskaya N et al. Dietary sodium restriction reduces arterial stiffness, vascular TGF-β-dependent fibrosis and marinobufagenin in young normotensive rats. Int J MolSci 2018;19(10): pii:E3168. doi: 10.3390/ijms19103168</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Grigorova YN, Juhasz O, Zernetkina V et al. Aortic fibrosis, induced by high salt intake in the absence of hypertensive response, is reduced by a monoclonal antibody to marinobufagenin. Am J Hypertens 2016;29(5):641–646. doi: 10.1093/ajh/hpv155</mixed-citation><mixed-citation xml:lang="en">Grigorova YN, Juhasz O, Zernetkina V et al. Aortic fibrosis, induced by high salt intake in the absence of hypertensive response, is reduced by a monoclonal antibody to marinobufagenin. Am J Hypertens 2016;29(5):641–646. doi: 10.1093/ajh/hpv155</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Ritz E., Mehls O. Salt restriction in kidney disease – a missed therapeutic opportunity? Pediatr Nephrol 2009; 24(1): 9–17. doi: 10.1007/s00467-008-0856-4</mixed-citation><mixed-citation xml:lang="en">Ritz E., Mehls O. Salt restriction in kidney disease – a missed therapeutic opportunity? Pediatr Nephrol 2009; 24(1): 9–17. doi: 10.1007/s00467-008-0856-4</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Mente A, O'Donnell M, Rangarajan S et al. Urinary sodium excretion, blood pressure, cardiovascular disease, and mortality: a community-level prospective epidemiological cohort study. Lancet 2018; 392(10146):496–506. doi: 10.1016/S0140-6736(18)31376-X</mixed-citation><mixed-citation xml:lang="en">Mente A, O'Donnell M, Rangarajan S et al. Urinary sodium excretion, blood pressure, cardiovascular disease, and mortality: a community-level prospective epidemiological cohort study. Lancet 2018; 392(10146):496–506. doi: 10.1016/S0140-6736(18)31376-X</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Kanbay M, Chen Y, Solak P, Sanders PW. Mechanisms and consequences of salt sensitivity and dietary salt intake. Curr Opin Nephrol Hypertens 2011; 20(1): 37–43. doi: 10.1097/MNH.0b013e32834122f1</mixed-citation><mixed-citation xml:lang="en">Kanbay M, Chen Y, Solak P, Sanders PW. Mechanisms and consequences of salt sensitivity and dietary salt intake. Curr Opin Nephrol Hypertens 2011; 20(1): 37–43. doi: 10.1097/MNH.0b013e32834122f1</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Mohan S, Campbell NR. Salt and high blood pressure. Clin Sci (Lond) 2009; 117(1): 1–11. doi: 10.1042/CS20080207</mixed-citation><mixed-citation xml:lang="en">Mohan S, Campbell NR. Salt and high blood pressure. Clin Sci (Lond) 2009; 117(1): 1–11. doi: 10.1042/CS20080207</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Oppelaar JJ, Vogt L. Body fluid-independent effects of dietary salt consumption in chronic kidney disease. Nutrients 2019; 11: 2779. doi: 10.3390/nu11112779</mixed-citation><mixed-citation xml:lang="en">Oppelaar JJ, Vogt L. Body fluid-independent effects of dietary salt consumption in chronic kidney disease. Nutrients 2019; 11: 2779. doi: 10.3390/nu11112779</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Hosohata K. Biomarkers for chronic kidney disease associated with high salt intake. Int J Mol Sci 2017; 18: 2080. doi: 10.3390/ijms18102080</mixed-citation><mixed-citation xml:lang="en">Hosohata K. Biomarkers for chronic kidney disease associated with high salt intake. Int J Mol Sci 2017; 18: 2080. doi: 10.3390/ijms18102080</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Wojciechowska A, Braniewska A, Kozar-Kamińska K. MicroRNA in cardiovascular biology and disease. Adv Clin Exp Med 2017; 26(5):865–874. https://doi.org/10.17219/acem/62915.6</mixed-citation><mixed-citation xml:lang="en">Wojciechowska A, Braniewska A, Kozar-Kamińska K. MicroRNA in cardiovascular biology and disease. Adv Clin Exp Med 2017; 26(5):865–874. https://doi.org/10.17219/acem/62915.6</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Wang X, Ning Y, Yang L et al. Diagnostic value of circulating microRNAs for osteosarcoma in Asian populations: a meta-analysis. Clin Exp Med 2017;17(2):175–183. https://doi.org/10.1007/s10238-016-0422-5.5</mixed-citation><mixed-citation xml:lang="en">Wang X, Ning Y, Yang L et al. Diagnostic value of circulating microRNAs for osteosarcoma in Asian populations: a meta-analysis. Clin Exp Med 2017;17(2):175–183. https://doi.org/10.1007/s10238-016-0422-5.5</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Oliveto S, Mancino M, Manfrini N et al. Role of microRNAs in translation regulation and cancer. World J Biol Chem 2017;8(1):45–56. https://doi.org/10.4331/wjbc.v8.i1.45</mixed-citation><mixed-citation xml:lang="en">Oliveto S, Mancino M, Manfrini N et al. Role of microRNAs in translation regulation and cancer. World J Biol Chem 2017;8(1):45–56. https://doi.org/10.4331/wjbc.v8.i1.45</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Li G, Song Y, Li YD et al. Circulating miRNA-302 family members as potential biomarkers for the diagnosis of acute heart failure. Biomark Med 2018;12(8):871–880. https://doi.org/10.2217bmm-2018-0132</mixed-citation><mixed-citation xml:lang="en">Li G, Song Y, Li YD et al. Circulating miRNA-302 family members as potential biomarkers for the diagnosis of acute heart failure. Biomark Med 2018;12(8):871–880. https://doi.org/10.2217bmm-2018-0132</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Каюков ИГ, Иванова ГТ, Зарайский МИ и др. Экспрессия микроРНК-21 в почечной ткани и моче у крыс с односторонней обструкцией мочеточника. Нефрология 2016; 20(5): 84–89</mixed-citation><mixed-citation xml:lang="en">Kayukov IG, Ivanova GT, Zaraisky MI, et al. Expression of microRNA-21 in renal tissue and urine in rats with unilateral ureteral obstruction. Nephrology (Saint-Petersburg) 2016;20(5):97–105. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Wang G. Elevated levels of miR-146a and miR-155 in kidney biopsy and urine from patients with IgA nephropathy. Dis Markers 2011; 30:171–179. doi: 10.3233/DMA-2011-0766.</mixed-citation><mixed-citation xml:lang="en">Wang G. Elevated levels of miR-146a and miR-155 in kidney biopsy and urine from patients with IgA nephropathy. Dis Markers 2011; 30:171–179. doi: 10.3233/DMA-2011-0766.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Yanai K, Kaneko S, Ishii H et al. Quantitative real-time PCR evaluation of microRNA expressions in mouse kidney with unilateral ureteral obstruction. J Vis Exp 2020; 27(162): 185–192. doi: 10.3791/61383</mixed-citation><mixed-citation xml:lang="en">Yanai K, Kaneko S, Ishii H et al. Quantitative real-time PCR evaluation of microRNA expressions in mouse kidney with unilateral ureteral obstruction. J Vis Exp 2020; 27(162): 185–192. doi: 10.3791/61383</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Metzinger-Le Meuth V, Metzinger L. miR-223 and other miRNA’s evaluation in chronic kidney disease: Innovative biomarkers and therapeutic tools. Non-Coding Rna Res 2019; 4: 30–35. doi: 10.1016/j.ncrna.2019.01.002</mixed-citation><mixed-citation xml:lang="en">Metzinger-Le Meuth V, Metzinger L. miR-223 and other miRNA’s evaluation in chronic kidney disease: Innovative biomarkers and therapeutic tools. Non-Coding Rna Res 2019; 4: 30–35. doi: 10.1016/j.ncrna.2019.01.002</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">He X, Zhang K, Gao X et al. Rapid atrial pacing induces myocardial fibrosis by down-regulating Smad7 via microRNA-21 in rabbit. Heart Vessel 2016; 31: 1696–1708. doi: 10.1007/s00380-016-0808-z</mixed-citation><mixed-citation xml:lang="en">He X, Zhang K, Gao X et al. Rapid atrial pacing induces myocardial fibrosis by down-regulating Smad7 via microRNA-21 in rabbit. Heart Vessel 2016; 31: 1696–1708. doi: 10.1007/s00380-016-0808-z</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Watanabe K, Narumi T, Watanabe T et al. P1626MicroRNA-21 deteriorates left ventricular reverse remodeling by promoting cardiac fibrosis in non-ischemic cardiomyopathy. Eur Heart J 2019; 40: 9–11</mixed-citation><mixed-citation xml:lang="en">Watanabe K, Narumi T, Watanabe T et al. P1626MicroRNA-21 deteriorates left ventricular reverse remodeling by promoting cardiac fibrosis in non-ischemic cardiomyopathy. Eur Heart J 2019; 40: 9–11</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Yousefi F, Shabaninejad Z, Vakili S et al. TGF-β and WNT signaling pathways in cardiac fibrosis: non-coding RNAs come into focus. Cell Communication and Signaling 2020; 18:87 https://doi.org/10.1186/s12964-020-00555-4</mixed-citation><mixed-citation xml:lang="en">Yousefi F, Shabaninejad Z, Vakili S et al. TGF-β and WNT signaling pathways in cardiac fibrosis: non-coding RNAs come into focus. Cell Communication and Signaling 2020; 18:87 https://doi.org/10.1186/s12964-020-00555-4</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Lyu H, Li X, Wu Q, Hao L. Overexpression of microRNA-21 mediates Ang II-induced renal fibrosis by activating the TGF-beta1/ Smad3 pathway via suppressing PPARalpha. J Pharmacol Sci 2019; 141: 70–78. doi: 10.1016/j.jphs.2019.09.007</mixed-citation><mixed-citation xml:lang="en">Lyu H, Li X, Wu Q, Hao L. Overexpression of microRNA-21 mediates Ang II-induced renal fibrosis by activating the TGF-beta1/ Smad3 pathway via suppressing PPARalpha. J Pharmacol Sci 2019; 141: 70–78. doi: 10.1016/j.jphs.2019.09.007</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">McClelland AD, Herman-Edelstein M, Komers R et al. miR- 21 promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7. Clin Sci 2015; 129: 1237–1249. doi: 10.1042/CS20150427</mixed-citation><mixed-citation xml:lang="en">McClelland AD, Herman-Edelstein M, Komers R et al. miR- 21 promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7. Clin Sci 2015; 129: 1237–1249. doi: 10.1042/CS20150427</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Ahmed MS, Calabria AC, Kirsztajn GM. Short-term effects of soy protein diet in patients with proteinuric glomerulopathies. J Bras Nefrol 2011; 33:150–159. doi: 10.1590/s0101-28002011000200006</mixed-citation><mixed-citation xml:lang="en">Ahmed MS, Calabria AC, Kirsztajn GM. Short-term effects of soy protein diet in patients with proteinuric glomerulopathies. J Bras Nefrol 2011; 33:150–159. doi: 10.1590/s0101-28002011000200006</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Береснева ОН, Парастаева ММ, Кучер АГ и др. Влияние содержания белка в диете на прогрессирование эксперимен- тальной хронической почечной недостаточности. Нефрология 89 ISSN 15616274. Нефрология. 2021. Том 25. №4 ISSN 15616274. Nephrology. 2021. Vol. 25. №4 2003; 7(4): 66–70</mixed-citation><mixed-citation xml:lang="en">Beresneva ON, Parastaeva MM, Kucher AG et al. Effect of protein content in the diet on the progression of experimental chronic renal failure. Nephrology(Saint-Petersburg) 2003;7(4):66–70. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Смирнов АВ, Кучер АГ, Добронравов ВА и др. Диетарный соевый протеин замедляет развитие интерстициального почечного фиброза у крыс с односторонней обструкцией мочеточника: введение в нутритивную эпигеномику. Нефрология 2012; 16(4): 75–83</mixed-citation><mixed-citation xml:lang="en">Smirnov AV, Kucher AG, Dobronravov VA et al. Dietary soy protein slows down the development of interstitial renal fibrosis in rats with unilateral ureteral obstruction: an introduction to nutritional epigenomics. Nephrology (Saint-Petersburg) 2012; 16(4):75–83. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Каюков ИГ, Береснева ОН, Парастаева ММ и др. Протеины сои противодействуют ремоделированию сердца у крыс Wistar, получающих рацион с высоким содержанием хлорида натрия. Нефрология 2019;23(6):92–99. doi: 10.36485/1561-6274-2019-236-92-99</mixed-citation><mixed-citation xml:lang="en">Kayukov IG, Beresneva ON, Parastaeva MM et al. Soybean proteins counteract heart remodeling in wistar rats fed a high sodium chloride diet. Nephrology (Saint-Petersburg) 2019;23(6):92– 99. (In Russ.) doi: 10.36485/1561-6274-2019-236-92-995</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Fouad M, Salem I, Elhefnawy K et al. MicroRNA-21 as an early marker of nephropathy in patients with type 1 diabetes. Indian J Nephrol 2020; 30(1): 21–22. doi:10.4103/ijn.IJN_80_19</mixed-citation><mixed-citation xml:lang="en">Fouad M, Salem I, Elhefnawy K et al. MicroRNA-21 as an early marker of nephropathy in patients with type 1 diabetes. Indian J Nephrol 2020; 30(1): 21–22. doi:10.4103/ijn.IJN_80_19</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Смирнов АВ, Карунная АВ, Зарайский МИ и др. Экспрессия микроРНК-21 в моче у пациентов с нефропатиями. Нефрология 2014; 18(6): 59–63</mixed-citation><mixed-citation xml:lang="en">Smirnov AV, Karunnaya AV, Zaraisky MI, et al. Expression of microRNA-21 in urine in patients with nephropathy. Nephrology (Saint-Petersburg) 2014; 18(6):59–63. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Wang JY, Gao YB, Zhang N et al. MicroRNA-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy. Mol Cell Endocrinol 2014; 392(1–2): 163–172. doi:10.1016/j.mce.2014.05.018</mixed-citation><mixed-citation xml:lang="en">Wang JY, Gao YB, Zhang N et al. MicroRNA-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy. Mol Cell Endocrinol 2014; 392(1–2): 163–172. doi:10.1016/j.mce.2014.05.018</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Ahmed MS, Calabria AC, Kirsztajn GM. Short-term effects of soy protein diet in patients with proteinuric glomerulopathies. J Bras Nefrol 2011; 33:150–159</mixed-citation><mixed-citation xml:lang="en">Ahmed MS, Calabria AC, Kirsztajn GM. Short-term effects of soy protein diet in patients with proteinuric glomerulopathies. J Bras Nefrol 2011; 33:150–159</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Deng B, Wang B, Fang J et al. MiRNA-203 suppresses cell proliferation, migration and invasion in colorectal cancer via targeting of EIF5A2. Sci Rep 2016;6:28301. doi: 10.1038/srep28301</mixed-citation><mixed-citation xml:lang="en">Deng B, Wang B, Fang J et al. MiRNA-203 suppresses cell proliferation, migration and invasion in colorectal cancer via targeting of EIF5A2. Sci Rep 2016;6:28301. doi: 10.1038/srep28301</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Kim JS, Choi DW, Kim CS et al. MicroRNA-203 induces apoptosis by targeting Bmi-1 in YD-38 oral cancer cells. Anticancer Res 2018; 38(6): 3477–3485. doi: 10.21873/anticanres.12618</mixed-citation><mixed-citation xml:lang="en">Kim JS, Choi DW, Kim CS et al. MicroRNA-203 induces apoptosis by targeting Bmi-1 in YD-38 oral cancer cells. Anticancer Res 2018; 38(6): 3477–3485. doi: 10.21873/anticanres.12618</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Zong L, Wang W. CircANXA2 promotes myocardial apoptosis in myocardial ischemia-reperfusion injury via inhibiting miRNA-133 expression. Biomed Res Int 2020;2020: 8590861. doi: 10.1155/2020/8590861.eCollection2020</mixed-citation><mixed-citation xml:lang="en">Zong L, Wang W. CircANXA2 promotes myocardial apoptosis in myocardial ischemia-reperfusion injury via inhibiting miRNA-133 expression. Biomed Res Int 2020;2020: 8590861. doi: 10.1155/2020/8590861.eCollection2020</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang XG, Wang LQ, Guan HL. Investigating the expression of miRNA-133 in animal models of myocardial infarction and its effect on cardiac function. Eur Rev Med Pharmacol Sci 2019; 23 (13):5934–5940. doi: 10.26355/eurrev_201907_18338</mixed-citation><mixed-citation xml:lang="en">Zhang XG, Wang LQ, Guan HL. Investigating the expression of miRNA-133 in animal models of myocardial infarction and its effect on cardiac function. Eur Rev Med Pharmacol Sci 2019; 23 (13):5934–5940. doi: 10.26355/eurrev_201907_18338</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
